Obesity Society Home
Learning Center Home
Using This Site
Annual Meetings
My Account
Search
Resources
Contact Us
Help
Log-in / Create Account
2009 Obesity Society Annual Scientific Meeting
Session List
Click
here
to search this conference.
Display sessions grouped by:
Track
Session Code
Speaker
Date
Track:
Track 1: Cell and Molecular Biology
Track 2: Integrative Biology
Track 3: Clinical Studies
Track 4: Population Studies
Track 5: Clinical/Professional Practice
Opening Session - President''s Lecture, George Bray Award and Lecture, and the Atkinson-Stern Award and Lecture
Mickey Stunkard Lifetime Achievement Award
Plenary Oral Abstract
TOPS Research Achievement Award and Lecture
Lilly Scientific Achievement Award and Lecture, Ethan Sims Young Investigator Award Finalists
Cell and Molecular Biology
Integrative Biology
Clinical Studies
Population Studies
Late Breaking Clinical Trial
Track 1: Cell and Molecular Biology
010 New Mechanisms for Regulating Adipogenesis
060 Molecular Mechanisms of Obesity-Related Cancer Risk
110 Obesity, Inflammation and Immune Dysfunction
150 Oral Abstracts Presenations - Cell and Molecular Biology - Metabolism
190 Asthma and Obesity
240 Oral Abstract Presentations - Cell and Molecular Biology - Cytokines and Other Secreted Factors
310 Genetics of Obesity: Complex Tools to Unravel a Complex Disease
350 Mitochondrial Dysfunction and Obesity
400 Oral Abstract Presentations - Cell and Molecular Biology - Adipose Tissue
510 Adiponectin: Not Lost in Translation
560 Oral Abstract Presentations - Cell and Molecular Biology - Mixed Abstracts
610 Hot Topics in Diabetes and Obesity Research
660 Obesity from Yeasties to Beasties
Back to Top
Track 2: Integrative Biology
070 Is There Good and Bad Body Fat?
200 Epigenetics and Obesity
250 Oral Abstract Presentations - Integrative Biology - GI Factors/Bypass
320 Inflammation, ER Stress in Brain and Obesity
360 Fat Additions and Subtractions
410 Oral Abstract Presentations - Integrative Biology - Insulin Resistance/Metabolic Syndrome
520 Advances in Obesity and Nonalcoholic Fatty Liver Disease
570 Oral Abstract Presentations - Integrative Biology - Central Effects
620 Advances in Chemoperception
670 Energy Restriction Models and Metabolic Outcomes
Back to Top
Track 3: Clinical Studies
030 Obesity Weight Loss and Cancer
080 Stress, Appetite, Obesity
160 Oral Abstract Presentations - Clinical Studies - Pharmacotherapy
170 Oral Abstract Presentations - Clinical Studies - Diet and Behavioral/Psychosocial
210 Spotlight on 5HT2C
260 Oral Abstract Presentatioins - Clinical Studies - Physiologic/Metabolic Studies
270 Oral Abstract Presentations - Clinical Studies - Pediatrics
330 Physical Activity in School - Worth the Effort?
370 How Big is the "Energy Gap" for Population Obesity Trend Estimates
420 Oral Abstract Presentations - Clinical Studies - Surgery
430 Oral Abstract Presentations - Clinical Studies - Diet or Physical Activity Interventions in Adults
480 Neuroimaging in Obesity
530 Emerging Concepts in Devices as Alternatives to Drugs and Surgery
580 Oral Abstract Presentations - Clinical Studies - Behavioral-Adult and Pediatric
590 Oral Abstract Presentations - Clinical Studies - Body Composition and Physical Activity
Back to Top
Track 4: Population Studies
040 The Next Generation: Novel Tools to Assess Diet and Physical Activity
090 Interventions to Prevent Excessive Weight Gain in Infants, Children and Pregnant Women
130 Moving Beyond Fit-Fat: The Science and Implications for Recommendations
180 Oral Abstract Presentations - Population Studies - Health Services/Mental Health/Interventions
220 Label, Label on the Wall: The Impact of Listing Nutritional Information on Menus
280 Oral Abstract Presentations - Population Studies - Pregnancy and Infancy
290 Oral Abstract Presentations - Population Studies - Economics, Policy and Context
380 Food and Beverage Marketing as Obesigenic Influences in Children's Environments: New Insights from New Lines of Research
440 Oral Abstract Presentations - Population Studies - Metabolism and Mortality
450 Oral Abstract Presentations - Population Studies - Population Genetics
490 Obesity and Pregnancy: Risks for Mother and Child
540 Key Lecture Dynamics of Global Obesity: The Evidence for Action to Address Food Policies - Jointly Sponsored with IASO
600 Oral Abstract Presentations - Population Studies - Diet and Physical Activity
680 Measuring Appetite Phenotypes in Children
Back to Top
Track 5: Clinical/Professional Practice
050 Drugs: Past, Present and Future
100 Medications and Obesity Comorbidities
140 Setting Up an Obesity Practice
230 Novel Diets for Childhood Obesity
300 Make Dollars and Sense: Reimbursement Strategies for Weight Management Programs
340 Adipose Tissue in Health and Disease: What's the Connection?
390 Medical Management of the Refractory Patient
500 Multidisciplinary Treatment of the Bariatric Surgery Patient
550 Behavioral Change for Obesity
650 Assessment Tools for Obesity: Beyond BMI
690 Eating Disorders
Back to Top
Opening Session - President''s Lecture, George Bray Award and Lecture, and the Atkinson-Stern Award and Lecture
GEN1 President's Address and Adward Session 1
Back to Top
Mickey Stunkard Lifetime Achievement Award
GEN2 Mickey Stunkard Lifetime Achievement Award
Back to Top
Plenary Oral Abstract
GEN3 Plenary Oral Abstract Presentations
Back to Top
TOPS Research Achievement Award and Lecture
GEN4 TOPS Research Achievement Award and Lecture
Back to Top
Lilly Scientific Achievement Award and Lecture, Ethan Sims Young Investigator Award Finalists
GEN5 Lilly Scientific Achievement Award and Lecture/Ethan Sims Young Investigator Award
Back to Top
Cell and Molecular Biology
SRC Test 2
Asthma and Obesity
Mitochondrial Dysfunction and Obesity
New Mechanisms for Regulating Adipogenesis
Obesity, Inflammation and Immune Dysfunction
Back to Top
Late Breaking Clinical Trial
Another Test
Effect of low-carb low-fat high-protein diet on the glycemic and lipid profiles of obese patients with metabolic syndrome.
EXERCISE EFFECTS ON INFLAMMATION AND LIVER HEALTH IN OVERWEIGHT CHILDREN
New Title
nutrition related knowledge and management practices of hypertensive adults in an urban community SA
Patient Directed, Bariatrician Treated: A Comprehensive Physician Based Medical (Non-Surgical) Weight Loss Program
Prevalence of Class II & III Obesity among Coal Mine Workers in Central Queensland Australia in 2008
Single incision transumbilical laparoscopic Roux-en-Y gastric bypass
testing one
460 Late Breaking Clinical Trial Symposium
P1080 THE EFFICACY OF LONG-TERM TREATMENT OF OBESITY WITH DIETHYLPROPION
P1081 Betahistine Is Safe and Effective in Mitigating Olanzapine Associated Weight Gain
P1082 Electronic feedback in a diet and physical activity-based lifestyle intervention for weight loss: randomized controlled trial
P1083 DXA Body Composition Measurements in Clinical Trials
P1084 Bariatric surgery and myocardial infarction: effect-modification of baseline fasting glucose in the prospective, controlled intervention trial Swedish Obese Subjects
P1085 Prevalence of Class II & III Obesity and other Cardiovascular Risk Factors among Coal Mine Workers in Central Queensland Australia in 2008
P1087 Effect of Omentectomy on Insulin Resistance in Obese Patients
P1088 Balancing and stabilising styles of eating behaviour in women with excess body weight and eating disorders of varying severity
P1089 Chewing Sugar Free-Gum Reduces Hunger Complaints In-Between Meals in Obese Children: Preliminary Results of a Prospective Study
P1090 Effects of 4 weight-loss diets differing in fat, protein, and carbohydrate on total body fat, lean mass, and visceral adipose tissue: Results from the POUNDS LOST trial.
P1091 Tackling child obesity in the UK: the MEND Program
P1092 Impact of rapid weight loss on moderate to severe obstructive sleep apnea: a randomized controlled trial
P1094 Pramlintide/metreleptin combination treatment for obesity: effect of dose and baseline BMI on magnitude of weight loss
P1095 Sleep, Obesity, Physical Activity, and Insulin Resistance in Adolescents
P1096 Results of the Phase 3, 56-week, COR-II Study: Naltrexone SR/Bupropion SR Combination Therapy Led to Significant and Sustained Weight Loss in Overweight and Obese Subjects
P1097 COR-I: A Phase 3 Study Evaluating Two Doses of Naltrexone SR/Bupropion SR Combination Therapy Showed Significant and Sustained Weight Loss in Overweight and Obese Subjects
Con Slide Subscription
Back to Top